At present, there are various clinical interventions for diabetes, including the administration of oral hypoglycaemic drugs
When Providers May Consider GLP-1 Therapy: Eligibility and Safety Conversations In rare casessuch as uncontrolled Type 2 diabetes or severe cardiovascular disease in a nursing parentproviders may weigh continued GLP-1 use against breastfeeding continuation
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications widely used for type 2 diabetes and obesity
Biguanides (e.g., Metformin): Hepatic glucose production and insulin sensitivity
People with Diabetes or Insulin Sensitivity Issues: Since IGF-1 has insulin-like effects and can alter glucose metabolism, individuals with type 1 or type 2 diabetes or those with insulin resistance may experience blood sugar fluctuations
Personal or family history of medullary thyroid cancer (MTC) : Due to the potential increased risk of MTC linked to Semaglutide GLP-1, people with a personal or family history of MTC should not use this medication
